SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc. announced today that the company will be participating in the Piper Jaffray 31st Annual Healthcare Conference in New York, December 3-5.
Progenity’s chief executive officer, Harry Stylli, PhD, will present a corporate overview on Wednesday, December 4, from 1:10 PM to 1:30 PM ET. Dr. Stylli and Eric d’Esparbes, chief financial officer, will also participate in one-on-one meetings with investors.
About Progenity
Progenity, Inc., is a privately held, biotechnology company with the mission of transforming healthcare to be more precise and personal. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics/epigenomics, proteomics, and microbiomics. These platforms feed an R&D pipeline of innovative products designed to improve patient outcomes in prenatal and perinatal healthcare settings, oncology, and gastroenterology. Progenity’s ultimate vision is to make precision medicine a reality by both diagnosing disease at its source and treating it with targeted therapies developed by the company. Progenity is headquartered in San Diego, California. For more information on how Progenity is helping clinicians and patients prepare for life, please visit www.progenity.com.
Contacts
Media Contact
Peggy Vorwald
CG Life
pvorwald@cglife.com (858) 457-2436
Investor Contact
IR@progenity.com